1. Background {#sec1}
=============

Marzotto et al. reported that a plant extract from *Arnica montana* L. from Boiron Laboratoires (Lyon, France) in 30% v/v EtOH/water contained 36.0 mg/100 ml of sesquiterpene lactones, namely 1.05 × 10^−3^ M. The 1:100 preparation named 1c, was used as the starting solution for a series of further 1:100 dilutions in 30% v/v EtOH/water, which showed an effect on the expression of some extracellular matrix genes when tested on IL-4 polarized THP-1 cells [@bib1]. The paper is particularly interesting but raised fundamental concerns about the experimental setting in basic Homeopathy, which is the objective of this article.

First, in order to calculate the molarity of sesquiterpene lactones in the alcoholic preparation, the authors referred to Staneva et al. who identified at least eight components in an *Arnica* extract related to helenalin and dihydrohelenalin by ^1^H NMR spectroscopy and assumed an average molar mass for dihydrohelenalin-derived compounds of 340.41 [@bib2]. The calculation evaluated by Marzotto et al. which does not rely on any reported chromatographic data, would be an approximation to the estimation done by Staneva et al. with ^1^H NMR. Staneva et al. reported possible errors in the quantitative analysis performed by using only the average molar mass, particularly for compounds such as methacryloyl-helenalin and assessing that the molar mass calculated by summing the molar weights of single lactones, particularly for isobutyryl-helenalin, 6-O-(2-methylbutyryl)-helenalin, 2-methylbutyryl dihydrohelenalin, which cannot be separately evaluated, was lower [@bib2]. The molar estimation calculated by Marzotto et al. in *Arnica* 1c should refer to the main sesquiterpene lactones present in *A*. *montana* (erroneously reported as *Arnica m*.), i.e. helenalin and 11α,13-dihydrohelenalin esters, giving the reported theoretical molarity [@bib1], [@bib2]. The *A*. *montana* 2c made in 30% v/v EtOH/water should therefore contain 51.43 mM EtOH and 10.5 nM sesquiterpene lactones. If considering helenalin and 11α,13-dihydrohelenalin as the major compounds from *A*. *montana* in the extract, the authors showed an effect using doses at least three orders of magnitude lower, than those ones previously reported as effective on *in vitro* immune cells [@bib1], [@bib3], [@bib4], [@bib5]. If true, this interesting result raises the conundrum of the activity associated with further dilutions, e.g. *Arnica* 5c, as this preparation should be made by 51.43 mM EtOH and 0.0001 fM sesquiterpene lactones, with a ratio EtOH/lactones = 5 × 10^14^ to 1, a circumstance for which it is very difficult to exclude the molar activity of ethanol with respect to the negligible one of lactones. The same UV--VIS performed by the authors on *Arnica* 1c shows clearly solely the UV absorbance of ethanol, at 205 nm for an A~1cm~ \> 1.0 at its lowest ε~M~ value [@bib1]. Therefore, the molar fraction of the chemical components in an *A*. *montana* L. extract, would suggest that ethanol is the only chemical bioactive species aside from water, which should be present in the centesimal dilutions.

2. Ethanol as a confounder and controls performance {#sec2}
===================================================

The role of ethanol should be better highlighted even though it is difficult to believe that the dilutions may work due to its existence. Ethanol was used in several experimental papers using homeopathic dilutions [@bib6], [@bib7], [@bib8], raising comments elsewhere [@bib9], [@bib10], [@bib11]. Verma et al. reported recently that ethanol is able to induce the release of nanosized membrane extracellular vesicles able to induce macrophage activation [@bib12]. There is no doubt that ethanol has a chemical activity in those systems where the molar mass of the active principle is absolutely negligible [@bib10], [@bib13], [@bib14]. However, the most frequent criticism to this comment is that ethanol is present both in controls and in herbal dilutions (cases) and hence, this solvent could not be considered a statistical confounding [@bib15]. If ethanol is present, at the same concentration, both in dilutions and in controls, its confounding effect should be negligible or even null. However, this is true only if both controls and cases are processed in a double blind fashion and are prepared with the same procedure and handling in a high stringency condition. Pre-analytical biases may occur in this case. Batch-derived biases were even reported for gene microarray, particularly in pooling the RNA samples [@bib16], [@bib17] and therefore, any difference in the handling, storage and treatment of the ethanol batches of dilutions may interfere and affect the reliability of the results. We must admit that, from a chemical point of view and based on the issues addressed above, a control 30% EtOH/water is perfectly similar to, e.g. an *Arnica* 15c into 30% ETOH/water, because both systems are practically made by only ethanol and water mixed together, due to the negligible or even null amount of sesquiterpene lactones (SLs) in the 15 [@bib1]. Therefore, researchers are most probably comparing two controls with each other, a "control" (A) vs a "dilution" (B). Furthermore, if B undergoes 0.22 μm filtration and A not, as reported [@bib1], if B comes from a batch stored for 12 months while A is a fresh preparation, if B comes from the serial dilutions of previous 4--5 iterative dilutions while A is made from only the previous dilution, and if a blind setting is not considered, differences in the batch of chemical systems that are practically controls at all, may generate bias in the statistics of the outputs and misunderstanding in the conclusive remarks on the reported evidence. Confounders are therefore occurring in the chemical activity of the solvent (ethanol) and in control biases.

3. A statistical evaluation can shed a light on possible biases {#sec3}
===============================================================

Controls should have a highly homogeneous distribution of their inner variance. Previous comments on data variability in experimental Homeopathy showed that even the distribution of standard error of mean (SEM) may lead to statistical significance, due to alpha error in a H~0~ null hypothesis [@bib9].

If controls have no homoscedasticity in their data distribution, then a control may bear a "biological" effect due to the existence of a chemical confounder. The herbal dilution with an EtOH/active principle ratio \> 10^10^ to 1, is practically a control, where the only chemical active species is the alcohol, as SLs are negligible or practically lacking [@bib1]. Ethanol has a specific activity on gene expression and on differentially expressed genes (DEGs) and may cause bias in the estimation of p values, particularly if performed with an approach, such as Friedman test, which has the very low power of the sign test [@bib14], [@bib18]. In this case, effects can be related to ethanol as the main confounder of the dilutions [@bib1], [@bib10], [@bib15].

To give a possible example of this issue, in a recent paper, statistics was performed using a Friedman sign test, which is less powerful than other non-parametric rank tests, such as the Wilcoxon--Mann Withney test [@bib1], [@bib18]. This evidence resembles previous reported data, with RT-PCR [@bib6]. According to the authors, any dilution in 30% v/v EtOH/water was able to change DEG patterns, with *p* \< 0.05 in a Wilcoxon test [@bib1]. An evaluation performed on data from Supplementary Tables in the paper [@bib1], using a non-parametric Wilcoxon--Mann Withney rank test, gave the results showed in [Table 1](#tbl1){ref-type="table"}. The simple matching of any dilution, from 3c to 15c, vs the control mean (averaging 5 separate experiments) using the RPKM values, gave the following results (bold character = non-significant, i.e. *p* \> 0.05 outputs).a)\[*A*. *montana* 2c\] *p* = 0.01108; \[*A*. *montana* 3c\] *p* = 0.01242; \[*A*. *montana* 5c\] *p* = 0.0226; \[*A*. *montana* 9c\] *p* = 0.01684; \[*A*. *montana* 15c\] *p* = 0.0477b)\[*A*. *montana* 2c\] *p* = **0.35238**; \[*A*. *montana* 3c\] *p* = **0.09102**; \[*A*. *montana* 5c\] *p* = **0.37346**; \[*A*. *montana* 9c\] *p* = **0.22628**; \[*A*. *montana* 15c\] *p* = **0.65994**, (bold character *p* \> 0.05, i.e. not significant), assessing therefore a circumstance that can be retrieved also from [Table 1](#tbl1){ref-type="table"}, [Table 2](#tbl2){ref-type="table"}, where dilutions are matched to controls of each single experiment. Data suggest that the variance distribution within the control series is not homogeneously dispersed and give possible biases in the interpretation of the presumptive working of homeopathic dilutions. To ascertain control homoscedasticity, a Bartlett\'s test should be accomplished. The Bartlett\'s test on the control distribution showed that this variability was highly significant (*p* \< 0.0001, χ^2^ = 409.19452). The overall RPKM evaluation of the signed rank comparison between all averaged controls and means for each tested dilution, gave the following statistics:Table 2Wilcoxon--Mann Whitney test of *A*. *montana* effects on IL-4 treated THP-1 gene expression (RPKM).[a](#tbl2fna){ref-type="table-fn"}Table 2SampleStatisticsTest 1Test 2W-valueMean differenceSum of POS ranksSum of NEG ranksZ-valueKolmogorov--Smirnov (P)P value (2-tailed)20Wilcoxon--U-Mann Whitney1 CTRLPooled 3c72−27.4772118−0.9296P = n.s.**0.35238**2 CTRL23918.55239257−0.1764P = 0.97184**0.85716**3 CTRL90−24.4790100−0.2012P = n.s.**0.84148**4 CTRL75−25.975115−0.8048P = n.s.**0.42372**5 CTRL74−27.3474116−0.8451P = n.s.**0.39532**20Wilcoxon--U-Mann Whitney1 CTRLPooled 5c75−29.7375115−0.8048P = n.s.**0.42372**2 CTRL40−31.7940150−2.2133P = 0.978080.02713 CTRL86−26.7386104−0.3622P = n.s.**0.71884**4 CTRL74−28.1674116−0.8451P = n.s.**0.39532**5 CTRL76−29.676114−0.7614P = n.s.**0.44726**20Wilcoxon--U-Mann Whitney1 CTRLPooled 9c91−22.819199−0.161P = n.s.**0.87288**2 CTRL53−26.2653118−1.4154P = 0.97184**0.1556**3 CTRL90−19.8190100−0.2012P = n.s.**0.84148**4 CTRL81−21.2481109−0.5634P = n.s.**0.57548**5 CTRL71−22.6871119−0.9658P = n.s.**0.33204**20Wilcoxon--U-Mann Whitney1 CTRLPooled 15c85−23,7110585−0.4024P = n.s.**0.68916**2 CTRL50−25.7750140−1.8109P = 0.97908**0.0703**3 CTRL83.5−20.7183.5106.5−0.4628P = n.s.**0.64552**4 CTRL84−22.1484106−0.4427P = 0.97908**0.65994**5 CTRL80−23.5880110−0.6036P = n.s.**0.5485**[^1]c)\[*A*. *montana* 2c\] *p* = **0.13622**; \[*A*. *montana* 3c\] *p* = **0.23404**; \[*A*. *montana* 5c\] *p* = **0.21498**; \[*A*. *montana* 9c\] *p* = **0.21499**; \[*A*. *montana* 15c\] *p* = **0.17702**, which should suggest the existence of a possible bias in the distribution used to evaluate the dilution activity on THP-1 cells, as these comparisons would indicate the complete absence of effects on the gene expression of macrophages by *A*. *montana* alcoholic extracts. This evidence seems to contradict the conclusive remark forwarded by the authors about the activity *o*f *Arnica* [@bib1]. Goodness of fit test, performed with a Shapiro--Wilk test and a Lilliefors-van Soers test assessed that any distribution was non parametric. The number of outliers in a Rosner\'s extreme studentized deviate test (*p* \< 0.00001, ≥10 out of values) was 2.25 higher for controls than for any test solutions.Table 1Wilcoxon--Mann Whitney test of *A*. *montana* effects on IL-4 treated THP-1 gene expression (RPKM).[a](#tbl1fna){ref-type="table-fn"}Table 1SampleStatisticsTest 1Test 2W-valueMean differenceSum of POS ranksSum of NEG ranksZ-valueKolmogorov--Smirnov (P)p value (2-tailed)20Wilcoxon--U-Mann Whitney1 CTRLPooled 3c34686.7417634−2.6506P = 0.983140.008042 CTRL55505.7915555−1.8666P = n.s.**0.06148**3 CTRL45637.0416545-2--24P = 0.98314**0.0251**4 CTRL12672.2919812−3.4719P = 0.983140.000525 CTRL33640.6417733−2.688P = n.s.0.0071420Wilcoxon--U-Mann Whitney1 CTRLPooled 5c35688.1417535−2.6133P = n.s.0.009062 CTRL43507.1943167−2.3146P = n.s.0.020883 CTRL51638.4415951−2.016P = n.s.0.043384 CTRL15673.6919515-3--3599P = 0.983140.000785 CTRL36642.0417436−2.576P = n.s.0.0098820Wilcoxon--U-Mann Whitney1 CTRLPooled 9c31689.8217931−2.7626P = n.s.0.005782 CTRL36508.8717436−2.576P = n.s.0.009883 CTRL48640.1216248−2.128P = n.s.0.033184 CTRL14675.3719614−3.3973P = 0.983140.000685 CTRL37643.7217337−2.5386P = n.s.0.0110820Wilcoxon--U-Mann Whitney1 CTRLPooled 15c38687.8917238−2.5013P = n.s.0.0012422 CTRL0506.940210−3.9199P = n.s.03 CTRL62638.1914862−1.6053P = n.s.**0.1074**4 CTRL11673.4419911−3.5093P = n.s.0.000445 CTRL40641.7917040−2.4266P = n.s.0.0151[^2]

Apparently, the authors did not seem to have addressed this concern. A possible reason is the following. The false discovery rate (FDR) approach has been standardized for barcoded cDNA of samples in a RNA-seq library and sequencing [@bib19] and actually sample pooling yet shows many critical aspects, so that the increase of replicate samples has been suggested as the best choice [@bib20]. Particularly, when negligible concentrations of active principle are challenged with an *in vitro* model of gene expression, a throughput RNA sequencing method should encompass stringent criteria for the statistical evaluation of DEGs In this context, even the concordance of an NGS with a gene microarray in the case of a genome-wide array of differential gene expression, is affected by the treatment effect size, depending by the transcript abundance and the biological complexity of the different modes of action of the tested chemicals, their dosage and ability to interact with genes [@bib21]. Interestingly, ethanol, at the concentration 51.43 mM, i.e. 0.03% v/v into water, is particularly active on a biological system. Ethanol may cause mitochondrial injury [@bib22] and even mitochondrial DNA damage [@bib23] and in doses as low as 50 mM of ethanol is able to cause mitochondria damage, oxidative stress and apoptosis in several cell models [@bib24], [@bib25], [@bib26], [@bib27], as 50 mM ethanol may cause 2.03% apoptosis in cardiomyocytes and 4.32% apoptosis in 24 h treated endothelial cells [@bib25], [@bib26]. In this circumstance, when ethanol is used in test homeopathic dilutions, an AnnexinV/PI or TUNEL test should be performed, besides a cytotoxicity assay [@bib1]. Ethanol, as a possible confounder should be virtually removed by introducing the same amount of ethanol in parallel matched controls. Controls and cases (i.e. tested dilutions) should be treated in a blinded or double blinded fashion, having the same procedural handling and matching the same experimental running [@bib28], [@bib29], [@bib30].

4. Possible further causes of high dilutions working {#sec4}
====================================================

While possible biases in statistics due to confounders might generate a misunderstanding in the interpretation of experimental Homeopathy, the question which arises here is that can ethanol help dilutions into water generating nanosized structures. According to some authoritative reports, nanobubbles might be generated upon the replacement of ethanol by water, as an effect of the super-saturation resulting from either the greater solubility of air gases in the alcohol than water or by the exothermal mixing of ethanol into water [@bib31], [@bib32]. Further detailed research has shown that the EtOH/water solvent usually contains large-scale structures within the range of 100 nm, a hallmark that seems to be commonly shared by any daylife used aqueous systems [@bib33]. This can be considered a "mesoscale inhomogeneity" with a long-lived feature and a relatively slow kinetics of formation that can be detected upon mixing the solutes and solvents. The nature of these structures has been recently investigated, also in EtOH/water mixtures, with static and dynamic light scattering, equilibrated with air at 1.0 atm and nanoparticle tracking analysis (NTA) and results did not confirm the hypothesis that these structures are nanobubbles stabilized by the solutes and contaminants adsorbed at the gas/solvent interface [@bib33]. Some authors performed an interesting study on the presence of nanosized structures, by using a NanoSight LM10 (Malvern), equipped with laser at 532 nm and the NanoSight NTA 3.0 analysis software to analyze data [@bib1]. Their graph has a bewildering similarity with the plot frame of the UV--VIS spectra, probably because the authors re-elaborated the NTA outputs with the same elaboration software used for the UV--VIS, yet not reported in the methods section. This cannot warrant for being fully aware of the NTA outputs and give a forthright comment about the interesting data of these nanostructures in *Arnica* 1c, namely if these nanostructures are really nanosized elements, nanobubbles or a mesoscale inhomogeneity. The plot represented in ref. [@bib1] about NTA was not released by the NanoSight NTA 3.0 analysis software [@bib1], [@bib34]. Actually, those structures might be either micro-nanobubbles (MNBs) or supra-molecular nanostructures, the authors should have better performed an analysis with optical microscopy by employing the total internal reflection fluorescence excitation (TIRF) to assess nanobubbles \> 100 nm [@bib35]. Further techniques adapted to detect nanosized structures in the dilutions, such as atomic force microscopy (AFM) or also CryoTEM, should be evaluated, in order to ameliorate the reliability of the reported results [@bib1].

MNBs are micro- or nanoscopic gas filled cavities which should derive from bubbles generated by a vigorous mixing of gases (generally from environmental air) into a liquid, where the mechanical stress should create a wide range of bubble diameters. Most of these air-filled cavities disappear rapidly, as they have a buoyancy that leads them to rise to the surface of the liquid and burst in equilibrium with the atmospheric pressure, according to Stoke\'s equation and following the nature of particles at low Reynolds number [@bib36], [@bib37]. According to the authors, these nanosized structures in *Arnica* 1c formed a colloidal heterogeneously polydispersed system, of about 1.83 × 10^8^ particles/ml with a mean dimension of 274 nm and a ζ-potential of −25.54 mV [@bib1]. The negative ζ-potential should suggest they are MNBs [@bib38]. Although the authors did not specify this, probably they caught aliquots from the bulk liquid. While most of nanobubbles are in the interface gas/liquid and in a lesser extent on the solid/liquid interfaces of the container walls, stable bulk MNBs have a half-life from 1.0 s to 100 μsec, particularly in water [@bib39], and probably the structures observed by Marzotto et al. are not MNBs [@bib40]. Moreover, ethanol, according to recent reports, cannot form surface nanobubbles, contrarily to other organic solvents such as formamide [@bib41]. Ethanol/water systems usually contain large-scale structures within the range of 100 nm, in a "mesoscale inhomogeneity" with a long-lived feature and a relatively slow kinetics of formation that can be detected upon mixing the solutes and solvents. Investigation with static and dynamic light scattering, equilibrated with air at 1.0 atm and nanoparticle tracking analysis (NTA) did not confirm the hypothesis that these structures are nanobubbles stabilized by the solutes and contaminants adsorbed at the gas/solvent interface [@bib33]. Furthermore, nanostructures with dimensions higher than 180 nm can be very rarely described as exosomes [@bib42]. When describing the theoretical composition of an *A*. *montana* 9c (final working concentration) the calculation should be as follows: a) Ethanol = 5.14 × 10^−4^ M; b) active principles (sesquiterpene lactones) = 1.05 × 10^−22^ M; c) supramolecular structures = unknown. In these conditions, the only chemical species appear to be the single ethanol. In this case, a great concern may be raised about the reliability of the reported results.

5. Conclusion {#sec5}
=============

Experimental setting in Homeopathy is particularly sensitive to bias, due to the very subtle mechanisms underlying the possibility that negligible doses of biochemical active principles cause effects on standardized and well suited *in vitro* biological models. Particularly for confounders, used also in solvents and for control setting, researchers must pay particular attention to the possibility that their analytical system might be tarnished by gross biases due to these confounders. Even statistics may hide bias due to an incorrect or not properly used statistical method.

In our opinion, in order to ascertain if the reported effects are caused by some chemical activity within the dilutions, the authors might address the bullet points recommended in [Table 3](#tbl3){ref-type="table"}.Table 3**A**. Bullet points of issues to be addressed, **B**. Possible bias in the experimental setting.Table 3IssueDescription**A**Herbal preparation■The analytical pattern of the herbal preparation (UV-HLPC, IR-HPLC, NMR, other) must be reported in any paper concerning herbal remedies.Dilutions■Each tested dilution should be evaluated for the presence of chemical molar mass, due to recent evidence and models [@bib43], [@bib44].■Nanosized particles and ζ-potential should be evaluated in each tested dilution.Nanoparticles■Reported results and plots must be produced directly from the NanoSight NTA analysis software upon throughput elaboration of data from the analytical instrument (e.g. NanoSight LM10 (Malvern).■An optical microscopy of the nanostructures (TIRF or AFM) should be considered for any dilution tested.Experimental setting■Double Blind fashion of the setting should be accomplished.■Batch effects on the microarray geneset evaluation.Controls■30% ethanol/water dilutions (sham) should be prepared and tested perfectly matched with any herbal dilution.Statistics■False discovery rate (FDR) analysis should be assessed by an improved estimation of p value based on the mixture model [@bib45], [@bib46].Minor points■In taxonomy the name of the genus is punctuated, the species not, e.g. *A*. *montana* instead of *Arnica m*..**B**Dilutions■Dilutions stored for at least 12 months may be not similar to fresh prepared controls.■Dilutions stored for at least 12 months allow readers to believe that the authors used the same preparations for different experimental studies. If a bias occurred in one dilution, a carry over effect might be created.Controls■Controls (sham dilutions) are not matched with cases because are prepared and treated in a different manner than cases (herbal dilutions) and without a double blind setting.Statistics and setting■Environmental EMF can cause bias in the statistics of microarray study [@bib47].■The use of Friedman test should be carefully addressed. Friedman test should be considered a generalization of the sign test and in this sense it has a modest statistical power of the sign test, both for normal and non normal distributions [@bib18].Pooling samples/data■Bias can be introduced when RNA samples are polled due to insufficient ability to test genesets. Pooling appears to lower the efficiency of the labeling or hybridization steps, causing artefacts, as reported in Kendziorski\'s experiment [@bib16],■Bias on microarray due to batch effects (RNA quality and RNA quantity) [@bib17].
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[^1]: Cluster 02 -- Controls. \[1 vs 2\] *p* = 0.25848; \[2 vs 3\] *p* = 0.14706; \[3 vs 4\] *p* = 0.90448; \[4 vs 5\] *p* = 0.27572; \[1 vs 3\] *p* = 0.68916; \[1 vs 4\] *p* = 0.63122; \[1 vs 5\] *p* = 0.4965; \[2 vs 4\] *p* = 0.29372; \[2 vs5\] *p* = 0.68916; \[3 vs 5\] *p* = 0.0703, **Bold letter**: biased or critical values. No control match is biased. Bartlett\'s tests on controls *p* = 0 χ^2^ = 409.19452.

[^2]: Cluster 01 -- **Controls**. \[1 vs 2\] *p* = **0.00026**; \[2 vs 3\] *p* = **0.00116**; \[3 vs 4\] *p* = **0.00068**; \[4 vs 5\] *p* = **0.01016**; \[1 vs 3\] *p* = **0.0151**; \[1 vs 4\] *p* = 0.05238; \[1 vs 5\] *p* = 0.07346; \[2 vs 4\] *p* = **0.00005**; \[2 vs5\] *p* = **0.10044**; \[3 vs 5\] *p* = 0.24604, **Bold letter**: biased or critical values. About 70% control matches are biased.
